Rhythm Pharmaceuticals (RYTM) Net Income Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Rhythm Pharmaceuticals | 6.00 Bn | 5.66 Bn | 52.96 Mn | -12.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.36% |
| Dec 31, 2025 | -9.64% |
| Sep 30, 2025 | -21.10% |
| Jun 30, 2025 | -44.43% |
| Mar 31, 2025 | 64.97% |
| Dec 31, 2024 | -4.07% |
| Sep 30, 2024 | 1.08% |
| Jun 30, 2024 | 30.92% |
| Mar 31, 2024 | -170.94% |
| Dec 31, 2023 | 2.02% |
| Sep 30, 2023 | -8.08% |
| Jun 30, 2023 | -4.09% |
| Mar 31, 2023 | 0.67% |
| Dec 31, 2022 | 16.44% |
| Sep 30, 2022 | -16.39% |
| Jun 30, 2022 | -26.79% |
| Mar 31, 2022 | -220.07% |
| Dec 31, 2021 | -45.73% |
| Sep 30, 2021 | -3.81% |
| Jun 30, 2021 | -13.73% |
| Mar 31, 2021 | 228.06% |
| Dec 31, 2020 | -5.89% |
| Sep 30, 2020 | 6.07% |
| Jun 30, 2020 | 27.29% |
| Mar 31, 2020 | -17.91% |
| Dec 31, 2019 | -29.20% |
| Sep 30, 2019 | -103.57% |
| Jun 30, 2019 | -196.95% |
| Mar 31, 2019 | -76.04% |
| Dec 31, 2018 | -142.21% |
| Sep 30, 2018 | -114.77% |
| Jun 30, 2018 | -114.46% |
| Mar 31, 2018 | -158.79% |
| Dec 31, 2017 | -25.88% |
| Sep 30, 2017 | -28.85% |